Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Zymeworks Inc ZYME

Healthcare Biotechnology
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ZYME)

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire March 5, 2025

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

GlobeNewswire February 26, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire February 25, 2025

Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors

GlobeNewswire February 18, 2025

Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025

GlobeNewswire February 13, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire January 30, 2025

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026

GlobeNewswire January 8, 2025

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases

GlobeNewswire December 12, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire November 21, 2024
View More News ››

Opinion & Analysis (NDAQ:ZYME)

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

Streetwise Reports June 10, 2019
View More Opinion ››

Bullboard Posts (NDAQ:ZYME)

Globe and Mail headline

Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
Possibleidiot01 - November 21, 2024

Zymeworks Inc. (NASDAQ:ZYME): Advancing a Diverse Pipeline o

http://beyondspx.com/2024/08/01/zymeworks-inc-nasdaqzyme-advancing-a-diverse-pipeline-of-novel-biotherapeutics/
MikeTester - August 2, 2024

Paradigm - cantechletter.com

Zymeworks gets a target trim from Paradigm Paradigm Capital analyst Scott McAuley lowered his target a notch on biopharma...
Possibleidiot01 - May 16, 2023

As some have noted..

Yesterday's quarterly and yearly results, smashed earnings and revenue estimates.  ZYME is ridiculously undervalued. ...
Gringotts - March 8, 2023

RE:ZYME contiuing it's trend up

And one she goes this morning. Over 8.70 and shows no signs of slowing down.
7Twiggy - November 15, 2022

ZYME contiuing it's trend up

Continues it's trend up.  Moved through 8.00 and showing a lot of strength these past two weeks.  Some good posts of Yahoo...
7Twiggy - November 10, 2022
View more Bullboard ››

Xcyte Digital Corp.

Xcyte Digital Corp.

Xcyte Digital is a virtual event company focused on simplifying the event hosting industry and expanding event hosting ...
View More »